Pubic pain
(UMLS:C0848197)
- UMLS ID:
- C0848197
- MeSH ID:
- N/A
Synonym(s)
1.
Pubic pain
2.
Pain;pubic;M
3.
pain pubic
4.
pubic pain
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 4 | US FAERS | |
| 2 | Acitretin | FAERS: 2 | US FAERS | |
| 3 | Atorvastatin | FAERS: 2 | US FAERS | |
| 4 | Thyroxine | FAERS: 2 | US FAERS | |
| 5 | strontium chloride | FAERS: 2 | US FAERS | |
| 6 | 17 alpha-Hydroxyprogesterone Caproate | FAERS: 1 | US FAERS | |
| 7 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 8 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 9 | Bethanechol | FAERS: 1 | US FAERS | |
| 10 | Bortezomib | FAERS: 1 | US FAERS | |
| 11 | Copper | FAERS: 1 | US FAERS | |
| 12 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 13 | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | FAERS: 1 | US FAERS | |
| 14 | Estrogens, Conjugated (USP) | FAERS: 1 | US FAERS | |
| 15 | Goserelin | FAERS: 1 | US FAERS | |
| 16 | Isotretinoin | FAERS: 1 | US FAERS | |
| 17 | Kombiglyze XR | FAERS: 1 | US FAERS | |
| 18 | Lenalidomide | FAERS: 1 | US FAERS | |
| 19 | Octreotide | FAERS: 1 | US FAERS | |
| 20 | Omeprazole | FAERS: 1 | US FAERS | |
| 21 | Rifaximin | FAERS: 1 | US FAERS | |
| 22 | cabazitaxel | FAERS: 1 | US FAERS | |
| 23 | pimecrolimus | FAERS: 1 | US FAERS | |
| 24 | regorafenib | FAERS: 1 | US FAERS | |
| 25 | Azithromycin | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Clotrimazole | OFFSIDES | ||
| 27 | Doxycycline | OFFSIDES | ||
| 28 | Ethambutol | OFFSIDES | ||
| 29 | Etoricoxib | OFFSIDES | ||
| 30 | Phenprocoumon | OFFSIDES | ||
| 31 | Raloxifene Hydrochloride | OFFSIDES | ||
| 32 | Tretinoin | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.